UPDATE: Citigroup Raises PT on Amdocs Following In-Line Results

In a report published Thursday, Citigroup analyst Ashwin Shirvaikar reiterated a Buy rating on Amdocs (NYSE: DOX ), and raised the price target from $41.00 to $44.00. In the report, Citigroup noted, “DOX remains a Buy and we are modestly raising our price target to $44 from $41 as we move